PUBLIC COMPANY
save$NXTCNextCure, Inc.
$NXTCBeltsville, MD, USupdated 21d ago
community read0 votes
pipeline
4
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(4)
pipeline depth4 products
1Preclinical2Phase 11Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
- phase1A Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
- phase1A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms
- phase1A Phase 1 Study of LNCB74 in Advanced Solid Tumors
- phase2A Safety and Tolerability Study of NC762 in Subjects With Advanced or Metastatic Solid Tumors
- phase2A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors
- phase2A Safety and Tolerability Study of NC410 in Subjects With Advanced or Metastatic Solid Tumors
- phase2A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors
🐶 Hiring Signal
News
no news has mentioned this company yet
Data sources
last refreshed 32m ago
Found something off?
comments(0)
5-min edit window · permanent after that